vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and Porch Group, Inc. (PRCH). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $121.1M, roughly 1.5× Porch Group, Inc.). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -3.9%, a 3.2% gap on every dollar of revenue. On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs 0.7%). Over the past eight quarters, Porch Group, Inc.'s revenue compounded faster (26.4% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.
AVNS vs PRCH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $121.1M |
| Net Profit | $-1.3M | $-4.7M |
| Gross Margin | 47.5% | 52.7% |
| Operating Margin | 1.4% | 34.7% |
| Net Margin | -0.7% | -3.9% |
| Revenue YoY | 0.7% | 100.0% |
| Net Profit YoY | 99.7% | 2.0% |
| EPS (diluted) | $-0.02 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $121.1M | ||
| Q4 25 | $180.9M | $112.3M | ||
| Q3 25 | $177.8M | $115.1M | ||
| Q2 25 | $175.0M | $107.0M | ||
| Q1 25 | $167.5M | $84.5M | ||
| Q4 24 | $179.6M | $75.3M | ||
| Q3 24 | $170.4M | $77.7M | ||
| Q2 24 | $171.7M | $75.9M |
| Q1 26 | — | $-4.7M | ||
| Q4 25 | $-1.3M | $-3.5M | ||
| Q3 25 | $-1.4M | $-10.9M | ||
| Q2 25 | $-76.8M | $2.6M | ||
| Q1 25 | $6.6M | $8.4M | ||
| Q4 24 | $-397.3M | $30.5M | ||
| Q3 24 | $4.3M | $14.4M | ||
| Q2 24 | $1.8M | $-64.3M |
| Q1 26 | — | 52.7% | ||
| Q4 25 | 47.5% | 99.5% | ||
| Q3 25 | 48.4% | 75.6% | ||
| Q2 25 | 52.6% | 70.9% | ||
| Q1 25 | 53.6% | 77.4% | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | 79.4% | ||
| Q2 24 | 55.7% | 22.1% |
| Q1 26 | — | 34.7% | ||
| Q4 25 | 1.4% | 14.7% | ||
| Q3 25 | 0.1% | 14.2% | ||
| Q2 25 | -42.6% | 4.7% | ||
| Q1 25 | 6.1% | -1.5% | ||
| Q4 24 | -233.0% | 33.3% | ||
| Q3 24 | 7.0% | -3.2% | ||
| Q2 24 | 3.7% | -69.2% |
| Q1 26 | — | -3.9% | ||
| Q4 25 | -0.7% | -3.1% | ||
| Q3 25 | -0.8% | -9.4% | ||
| Q2 25 | -43.9% | 2.4% | ||
| Q1 25 | 3.9% | 9.9% | ||
| Q4 24 | -221.2% | 40.5% | ||
| Q3 24 | 2.5% | 18.5% | ||
| Q2 24 | 1.0% | -84.8% |
| Q1 26 | — | $-0.04 | ||
| Q4 25 | $-0.02 | $0.00 | ||
| Q3 25 | $-0.03 | $-0.10 | ||
| Q2 25 | $-1.66 | $0.00 | ||
| Q1 25 | $0.14 | $0.07 | ||
| Q4 24 | $-8.64 | $0.34 | ||
| Q3 24 | $0.09 | $0.12 | ||
| Q2 24 | $0.04 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $68.4M |
| Total DebtLower is stronger | $90.3M | $391.3M |
| Stockholders' EquityBook value | $778.2M | $26.3M |
| Total Assets | $1.1B | $806.6M |
| Debt / EquityLower = less leverage | 0.12× | 14.87× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $68.4M | ||
| Q4 25 | $89.8M | $57.3M | ||
| Q3 25 | $70.5M | $85.0M | ||
| Q2 25 | $90.3M | $79.8M | ||
| Q1 25 | $97.0M | $70.4M | ||
| Q4 24 | $107.7M | $191.7M | ||
| Q3 24 | $89.0M | $238.6M | ||
| Q2 24 | $92.2M | $308.4M |
| Q1 26 | — | $391.3M | ||
| Q4 25 | $90.3M | $392.8M | ||
| Q3 25 | $93.4M | $387.1M | ||
| Q2 25 | $95.7M | $394.1M | ||
| Q1 25 | $98.0M | $409.2M | ||
| Q4 24 | $125.3M | $403.9M | ||
| Q3 24 | $152.6M | $399.0M | ||
| Q2 24 | $164.9M | $436.8M |
| Q1 26 | — | $26.3M | ||
| Q4 25 | $778.2M | $-24.6M | ||
| Q3 25 | $778.0M | $-27.9M | ||
| Q2 25 | $776.3M | $-29.3M | ||
| Q1 25 | $839.4M | $-52.4M | ||
| Q4 24 | $828.5M | $-43.2M | ||
| Q3 24 | $1.2B | $-77.0M | ||
| Q2 24 | $1.2B | $-101.9M |
| Q1 26 | — | $806.6M | ||
| Q4 25 | $1.1B | $797.4M | ||
| Q3 25 | $1.1B | $787.7M | ||
| Q2 25 | $1.0B | $770.7M | ||
| Q1 25 | $1.1B | $802.3M | ||
| Q4 24 | $1.2B | $814.0M | ||
| Q3 24 | $1.7B | $867.3M | ||
| Q2 24 | $1.7B | $876.1M |
| Q1 26 | — | 14.87× | ||
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | — |
| Free Cash FlowOCF − Capex | $21.3M | — |
| FCF MarginFCF / Revenue | 11.8% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $28.2M | $1.2M | ||
| Q3 25 | $14.0M | $40.8M | ||
| Q2 25 | $6.8M | $35.6M | ||
| Q1 25 | $25.7M | $-11.2M | ||
| Q4 24 | $57.9M | $-26.6M | ||
| Q3 24 | $23.0M | $12.4M | ||
| Q2 24 | $27.8M | $-26.0M |
| Q1 26 | — | — | ||
| Q4 25 | $21.3M | $1.1M | ||
| Q3 25 | $7.0M | $40.7M | ||
| Q2 25 | $-4.2M | $35.4M | ||
| Q1 25 | $19.0M | $-11.2M | ||
| Q4 24 | $53.1M | $-26.8M | ||
| Q3 24 | $20.0M | $12.2M | ||
| Q2 24 | $21.9M | $-26.0M |
| Q1 26 | — | — | ||
| Q4 25 | 11.8% | 1.0% | ||
| Q3 25 | 3.9% | 35.4% | ||
| Q2 25 | -2.4% | 33.0% | ||
| Q1 25 | 11.3% | -13.3% | ||
| Q4 24 | 29.6% | -35.6% | ||
| Q3 24 | 11.7% | 15.7% | ||
| Q2 24 | 12.8% | -34.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.8% | 0.1% | ||
| Q3 25 | 3.9% | 0.1% | ||
| Q2 25 | 6.3% | 0.2% | ||
| Q1 25 | 4.0% | 0.1% | ||
| Q4 24 | 2.7% | 0.3% | ||
| Q3 24 | 1.8% | 0.3% | ||
| Q2 24 | 3.4% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 13.79× | ||
| Q1 25 | 3.89× | -1.33× | ||
| Q4 24 | — | -0.87× | ||
| Q3 24 | 5.35× | 0.86× | ||
| Q2 24 | 15.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
PRCH
Segment breakdown not available.
